ClinicalTrials.gov
ClinicalTrials.gov Menu

HFS in the Assessement and Management of Severe Asthma Attack Among Fifth Year Medical School Students (SimAG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02776358
Recruitment Status : Completed
First Posted : May 18, 2016
Last Update Posted : May 18, 2016
Sponsor:
Information provided by (Responsible Party):
Pr. Semir Nouira, University of Monastir

Brief Summary:

Bedside clinical case learning, such for respiratory distress, represent a challenge for medical teachers, especially in critical conditions. In fact, this kind of learning implicate the presence of an appropriate case (the patient itself), framework and may be time consuming which could compromise the patient's safety and wellbeing.

New pedagogic tools have emerged to strengthen the medical reasoning and the acquisition of knowledge. in recent years, the development of medical simulation has found a growing interest in the medical teaching field. Contextualization, reproducibility and reliability are the characteristics of high-fidelity simulation (HFS) which guarantee a lifetime experience of clinical conditions without putting at risk patient's safety and comfort.

The aim of this study is to assess the impact of HFS on fifth year medical students learning skills in the assessement and management of an acute asthma attack in the emergency room, and to compares it to other modern teaching tools such as "video-case"


Condition or disease Intervention/treatment Phase
Asthma Other: High Fidelity Simulation Other: Video case Phase 1

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 33 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: High Fidelity Simulation (HFS) Versus Video-case(VC) Trainings in the Assessement and Management of Severe Asthma Attack Among Medical School Students: a Randomized Controlled Study
Study Start Date : September 2014
Actual Primary Completion Date : May 2015
Actual Study Completion Date : May 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma
U.S. FDA Resources

Arm Intervention/treatment
Experimental: High Fidelity Simulation
Students will receive a 1 hour High fidelity simulation session
Other: High Fidelity Simulation

A HFS session for an asthma attack require:

  • a 5 minutes briefing session: case and equipments presentation and choice of participants
  • 15 minutes of actual simulation
  • 40 minutes of debriefing

A pre and a post test will be taken by the students before and after the session and a satisfaction questionnaire at the end of the course.

Also, another test will be done after 7 days of the course.

Experimental: Video Case
Students will receive a 1 hour assisted Video Case learning session
Other: Video case

a video case (or video box) session in which students will attend a video-projection of a real case of an asthma attack and discuss with the trainer the different steps of the assessement and management of an asthma attack.

A pre and a post test will be taken by the students before and after the session and a satisfaction questionnaire at the end of the course.

Also, another test will be done after 7 days of the course.




Primary Outcome Measures :
  1. Difference between the pre and the post-test scores in each group (delta Score) [ Time Frame: Just before the teaching course (baseline) and one hour later ]

    The difference between the pre and the post-test scores is calculated as follow:

    delta score = post-test score - pre-test score



Secondary Outcome Measures :
  1. Late performance score [ Time Frame: 7 days after the teaching course ]
    This score is calculated based on a test taken 7 days after the teaching course to assess the students memory of the clinical case and acquired knowledge.

  2. Level of satisfaction [ Time Frame: one hour after the teaching course ]
    A five point likert scale is given to each student to assess their level of satisfaction regarding the teaching technique.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • all fifth year medical students allocated to the one month internship period in the emergency departement.

Exclusion Criteria:

  • students refusing to participate in the protocol.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02776358


Locations
Tunisia
university of Monastir
Monastir, Tunisia, 5000
Sponsors and Collaborators
University of Monastir
Investigators
Principal Investigator: Mohamed habib Grissa, MD Emergency Department , university hospital of Monastir, TUNISIA
Principal Investigator: Nouira Semir, Professor Emergency Department , university hospital of Monastir, TUNISIA

Responsible Party: Pr. Semir Nouira, Clinical Professor, University of Monastir
ClinicalTrials.gov Identifier: NCT02776358     History of Changes
Other Study ID Numbers: SimAG
First Posted: May 18, 2016    Key Record Dates
Last Update Posted: May 18, 2016
Last Verified: May 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases